US Senator Grassley continues work for transparency of drug company money in medicine; patent settlement ban off House agenda?
US Senator Charles Grassley (Republican, Iowa, and Ranking Member of the Committee on Finance) has asked leaders among pharmacy benefit managers (PBMs) to describe their efforts to enhance the transparency of financial benefits they receive from drug makers. He also requested the PBMs' views on recommendations from the Medicare Payment Advisory Commission that PBMs be subject to a national disclosure requirement.
The bipartisan Physician Payments Sunshine Act, which Sen Grassley co-authored with Senator Herb Kohl (Democrat, Wisconsin), would require annual public reporting by drug, device and biologic manufacturers of payments made to physicians nationwide.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
| Headless Content Management with Blaze